Alzheimer’s disease (AD) remains a major cause of morbidity and mortality worldwide, and
despite extensive research, only a few drugs are available for management of the disease. …

… and may be of benefit in Alzheimer's disease. In the present study, … In this research study,
number of Nissl-stained neurons per … suggest no involvement of muscarinic or nicotinic receptor …

… Alzheimer's disease (AD), also known as Alzheimer's … encompass the marginal cortex and
prefrontal lobe, and not the … the decrease of the muscarinic cholinoreceptor. Scopolamine can …

… Alzheimer's disease is a neurodegenerative disease that … -β protein plaques in neurons and
hyperphosphorylation of … in long-term depression in the prefrontal cortex and the potential for …

… of the prefrontal cortex and parietal association areas display the … of neuronal precursors
supplying neurons to expanding … [91], activation of M1 and M3 muscarinic AChR suppresses the …

… and RNA processing in the prefrontal cortex (Martyn et al. 2012; … to modulate the neuronal
activity in the entorhinal cortex (EC), … circuits: implications for treatment of Alzheimer disease. …

… AD patients suffer loss of ACh in cholinergic neurons and this results in the impairment of
cognitive functions. Furthermore, loss of cholinergic neurons in the … In the brain, the muscarinic …

… muscarinic AChRs (nAChRs and mAChRs, respectively) in human hippocampal neurons …
prefrontal cortex, functionally express nAChRs. In these studies, however, the iPSC-derived …

… Briefly, hippocampus and prefrontal cortex were dissected and … Cholinergic neurons are
widely distributed in cortex and … use of turmeric in Alzheimer's disease. Pharmacol Biochem …

… The initial stage involves the accumulation of granular tau oligomers in the frontal cortex, …
and muscarinic acetylcholine receptors due to marked degeneration of cholinergic neurons …